-
admin
Posts
JellyFit Claims Evaluated: The Truth About Jelly Lean Fit Weight Loss Drops’ 8 Ingredients Stacked with Gelatin Trick Recipe Hack Exposed
JellyFit’s 8-Ingredient Liquid Weight Loss Drops: Apple Cider Vinegar, Apple Pectin, Beet Root, and the Gelatin Trick Formula Explained for 2026 Largo, FL, May 04,...
How Hiring Veterans Can Strengthen the Workforce
NEW YORK, May 04, 2026 (GLOBE NEWSWIRE) — (Feature Impact) Every year, about 200,000 service members transition from military service into civilian careers, offering employers...
When the Heart Can’t Keep Up: What to Know About Heart Failure
NEW YORK, May 04, 2026 (GLOBE NEWSWIRE) — (Feature Impact) For decades, heart disease has been the leading cause of death in the United States,...
Awareness is Key: 3 Steps to Help Recognize Stroke Signs and Risks for Better Outcomes
NEW YORK, May 04, 2026 (GLOBE NEWSWIRE) — (Feature Impact) A stroke can happen to anyone at any age. A Media Snippet accompanying this announcement...
Sonilo Eliminates Text Prompts in AI Music, Generates Soundtracks Directly from Video
New platform generates custom soundtracks from video in seconds, eliminating text prompts and manual editing. MENLO PARK, Calif., May 5, 2026 /PRNewswire/ — Sonilo, a...
Guesty and Alloggio announce strategic partnership to power full portfolio migration across ANZ
Alloggio has selected Guesty’s PMS and Channel Manager as its core platform and will scale it across its full portfolio, while joining as a design...
LRQA highlights shift from compliance-led security to continuous assurance at BrisSEC AISA 2026
BRISBANE, Australia, May 5, 2026 /PRNewswire/ — BrisSEC AISA 2026 highlighted growing strain on Australia’s cybersecurity model, as organisations face overlapping pressures from rising threat activity...
Cellenkos Announces FDA Clearance of Investigational New Drug (IND) Application for Phase 1b/ 2a Trial of CK0802 in Steroid-Refractory Graft-versus-Host Disease (GVHD)
Multicenter, open-label study will evaluate the safety and preliminary efficacy of CK0802, a first-in-class, off-the-shelf Treg therapy, in patients with steroid-refractory GVHD HOUSTON, May 5,...
PMET Advances Flagship Shaakichiuwaanaan Project Towards Next Development Tier
MONTREAL, May 5, 2026 /PRNewswire/ — May 5, 2026 – Sydney, Australia HIGHLIGHTS Environmental and Social Impact Assessment (ESIA) for the Shaakichiuwaanaan Project submitted to...
Loblaw Partners with Canadian AI Company Shakudo to Accelerate Its AI Adoption and Deployment
TORONTO, May 04, 2026 (GLOBE NEWSWIRE) — Loblaw Companies Limited (TSX: L; “Loblaw” or the “Company”) has partnered with Canadian technology firm Shakudo, as the...
